Abstract
In our previous studies, L-aspartic acid (L-ASP) was found to antagonize the inhibitory effects of acute and chronic morphine (M) administration on brain L-asparaginase activity, the developement of physical dependence on M and the manifestation of M abstinence syndrome (19, 21, 24, 26). As a result of these experimental data, we hypothesized that the mechanisms underlying the development of physical dependence on opiates and the abstinence syndrome upon withdrawal from opiates are the inhibition by opiates of the brain L-asparaginase and glutaminase activities, and the disequilibrium due to the inhibitory effect of opiates between L-asparaginase and asparagine synthetase +L-glutaminase and glutamine synthetase (14, 20, 40). As a consequence, the inhibition of the brain L-asparaginase and glutaminase activities, and the subsequent relative hyperactivities of asparagine and synthetases result in less production of the excitatory neurotransmitter amino acids (EAAs), namely ASP and L-glutamic acid (L-GLU), and prompt adaptation of the organism to this newly created state. The similar effects of another L-asparaginase inhibitor D-ASP (30) to those of M (15, 17), the intensification or attenuation by D-ASP administered at the beginning of the M physical dependence development or just before the naloxone precipitated abstinence syndrome (22), and the successful treatment with L-ASP (14, 40) of opiate addicted people have been considered to be supporting evidence for the hypothesis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aanonsen LM, Wilcox GL (1987) Nociceptive action of excitatory amino acids in the mouse; effects of spinally administered opioids, phencyclidine and sigma agonists. J Pharmacol Exp Ther 243: 9–19
Anis NA, Berry SC, Burton NR, Lodge D (1983) The dissociative anesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurons by N-methyl-Laspartate. Br J Pharmacol 71: 565–575
Arenas E, Alberch J, Arroyos RS, Mersal J (1990) Effects of opioids on acetylcholine release evoked by K or glutamic acid from rat neostriatal slices. Brain Res 523: 51–56
Bielarczyk H, Lysiak W, Szutowicz A (1986) Synthesis of glutamate and aspartate in rat brain synaptosomes. Acta Biochim Pol 33: 239–251
Choi DW, Peter S, Viseskul V (1987) Dextrorphan and levorphanol selectively block N-methyl-Daspartate receptor-mediated neurotoxicity on cortical neurons. J Pharmacol Exp Ther 242: 713–720
Choi DW, Viseskul V (1988) Opioids and non-opioid enantiomers selectively attenuate N-methylD- aspartate neurotoxicity on cortical neurons. Eur J Pharmacol 155: 27–35
Ferkany JW, Borosky SH, Clissold DB, Pontecorvo MJ (1988) Dextromethorphan inhibits NMDA induced convulsions. Eur J Pharmacol 151: 151–154
George CP, Goldberg MP, Choi DW, Steinberg GK (1988) Dextromethorphan reduces neocortical ischemic damage in vivo. Brain Res 440: 375–379
Isbell H, Fraser HF (1953) action and addiction liabilities of dromoran derivatives in man. J Pharmacol Exp Ther 107: 524–530
Jasinski DR, Martin WR, Mansky PA (1971) Progress report on the assessment of the antagonists nalbuphine and GPA-2087 for abuse potential and studies of the effects of dextromethorphan in man. Presented at 33rd Meeting of Committee on Problems of Drug Dependence, National Research Council, Toronto, Ontario, Canada
Jones SM, Snell LD, Johnson KM (1987) Phencyclidine selectively inhibits N-methyl-D-aspartateinduced hippocampal [H]-norepinephrine release. J Pharmacol Exp Ther 240: 492–497.
Jones SM, Snell LD, Johnson KM (1987) Inhibition by phencyclidine of excitatory amino-acidstimulated release of neurotransmitter in the nucleus accumbens. Neuropharmacol 26: 173–179.
Klein M, Paturzo JJ, Musacchio JM (1989) The effects of prototypic ligands on the binding of [H] dextromethorphan to guinea pig brain. Neurosci Lett 97: 175–180
Koyuncuodlu H (1983) The treatment with L-aspartic acid of persons addicted to opiates. Bull Narcotics 35: 11–15
Koyuncuoÿlu H, Berkman K (1982) Effect of D- and/or L-aspartic acids on feeding, drinking, urine outflow and core temperature. Pharmacol Biochem Behav 17: 1265–1269.
Koyuncuoÿlu H, Saydam B (1990) The treatment of heroin addicts with dextromethorphan: A double blind comparison of dextromethorphan with chlorpromazine. Int J Clin Pharmacol Ther Toxicol 28: 147–152.
Koyuncuo§lu H, Berkman K, Sabuncu H (1984) Feeding, drinking, urine osmolality in Brattleboro rats: Changes by morphine, naloxone, D-amino acids, PLG. Pharmacol Biochem Behav 20: 29–34.
Koyuncuoglu H, Berkman K, Widmann J, Matthaei H (1982) Antagonistic effect of L-aspartic acid on decrease in body weight, food and fluid intake, and naloxone reversible rectal temparature caused by D-aspartic acid. PoI J Pharmacol Pharm 34: 333–337.
Koyuncuoglu H, Genç E, Güngòr M, Eroglu L, Sagduyu H (1977) The antagonizing effect of aspartic acid on the brain levels of monoamines and free amino acids during the development tolerance and physical dependence on morphine. Psychopharmacology (Berlin) 54: 187–191.
Koyuncuoglu H, Güngör M, Enginar N, Hatipoglu Ì, Hizal A (1986) Brain asparaginase, ACE activity and plasma cortisol level in morphine dependent rats: Effect of aspartic acid and naloxone. Pharmacol Biochem Behav 25: 953–957
Koyuncuoglu H, Güngör M, Eroglu L, Sagduyu H 1979 (a) The antagonizing effect of aspartic acid on morphine withdrawal and levallorphan precipitated abstinence syndrome signs and on associated changes in brain levels of free amino acids in the rat. Psychopharmacology (Berlin) 62: 89–95
Koyuncuoglu H, Güngör M, Sagduyu H, Aricioglu F (1990) Intensification and attenuation of morphine dependence by D-aspartic acid and PLG. Pharmacol Biochem Behav 35: 47–50
Koyuncuoglu H, Güngör M, Sagduyu H, Ancioglu F (1990) Suppression by ketamine and dextromethorphan of precipitated abstinence syndrome in rats. Pharmacol Biochem Behav 35: 829–832
Koyuncuoglu H, Güngör M, Sagduyu H, Eroglu L (1974) The antagonistic effects of aspartic acid on some effects of morphine on rats. Eur J Pharmacol 27: 148–150
Koyuncuoglu H, Keyer-Uysal M, Berkman K, Güngòr M, Genç E (1979) The relationship between morphine, aspartic acid and L-asparaginase in rats. Eur J Pharmacol 60: 369–372
Koyuncuoglu H, Güngòr M, Sagduyu H, Eroglu L, Genç E (1977) Antagonizing effect of aspartic acid on the development of physical dependence on and tolerance to morphine in the rats. Drug Res 27: 1676–1679
Koyuncuoglu H, Wildmann J, Berkman K, Matthaei (1982) The effects of D- and/or L-aspartic acid on the total weight of body and the weights of certain organs, and their protein, triglyceride and glycogen contents. Drug Res 32: 738–741
Lakes M, Middlemiss DN, Ransom R (1988) Stereoselective antagonism of NMDA-stimulated noradrenaline release from rat hippocampal slices by MK-801. Neurosci Letts 91: 339–342
Lehmann J, Scatton B (1982) Characterization of the excitatory amino acid receptor-mediated release of [HI-acetylcholine from rat striatal slices. Brain Res 252: 77–89
Lerman MI, Verevkina IV (1962) The inhibition of asparaginase from the blood serum of guinea pigs. Biokhimiya 27: 556–561
Mason GA, Bisette G, Nemeroff CB (1983) Effects of excitotoxic aminoacids on pituitary hormone secretion in the rat. Brain Res 289: 366–369
Mansky PA, Jasinski DR (1970) Effects of dextromethorphan ( D) in man. Pharmacologist 12: 231
Massachio JM, Klein M, Santiago W (1988) High affinity dextromethorphan binding sites in guinea pig brain: further characterization and allosteric interactions. J Pharmacol Exp Ther 247: 424–431
Price MT, Olney JW, Mitchell MV, Fuller T, Cicero TJ (1978) Luteinizing releasing action of N-methyl aspartate is blocked by GABA or taurine but not by dopamine antagonists. Brain Res 158: 461–466
Price MT, Olney JW, Anglim M, Buchsbaum S (1979) Reversible action of N-methyl aspartate on gonadotropin neuroregulation. Brain Res 176: 165–168
Ransom RW, Deschenes NL (1989) Glycine modulation of NMDA-evoked release of [H]-acetylcholine and [HI-dopamine from rat striatal slices. Neurosci Lett 96: 323–327
Reubi JC, Toggenburger G, Cuenod M (1980) Asparagine as precursor for transmitter aspartate in corticostriatal fibers. J Neurochem 34: 1015–1017
Snell LD, Johnson KM (1985) Antagonism of NMDA-induced transmitter release in the rat striatum by phencyclidine-like drugs and its relationship to turning behavior. J Pharmacol Exp Ther 235: 50–57
Snell LD, Johnson KM (1986) Characterization of the inhibition of excitatory amino acid-induced neurotransmitter release in the rat striatum by phencyclidine-like drugs. J Pharmacol Exp Ther 238: 938–946
mener AÌ, Ceylan ME, Koyuncuoÿlu H (1986) Comparison of the suppressive effects of L-aspartic acid and chlorpromazine + diazepam treatments on opiate abstinence syndrome signs in men. Drug Res 36: 1684–1686
Trujillo KA, Akil H (1991) Inhibition of morphine tolerance and dependence by NMDA receptor antagonist MK-801. Science 251: 85–87
Vezzani A, Wu HQ, Samanin R (1987) [H]-norepinephrine release from hippocampal slices is an in vitro tool for investigating the pharmacological properties of excitatory amino acids. J Neurochem 49: 1438–1432
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag/Wien
About this paper
Cite this paper
Koyuncuoğlu, H. (1991). The Treatment with Dextromethorphan of Heroin Addicts. In: Loimer, N., Schmid, R., Springer, A. (eds) Drug Addiction and AIDS. Springer, Vienna. https://doi.org/10.1007/978-3-7091-9173-6_38
Download citation
DOI: https://doi.org/10.1007/978-3-7091-9173-6_38
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-82298-2
Online ISBN: 978-3-7091-9173-6
eBook Packages: Springer Book Archive